Vagus nerve stimulation therapy for epilepsy in older adults.
Publication/Presentation Date
3-14-2000
Abstract
The authors assessed the efficacy, safety, and tolerability of vagus nerve stimulation (VNS) for refractory epilepsy in 45 adults 50 years of age and older. They determined seizure frequency, adverse effects, and quality of life. At 3 months, 12 patients had a >50% decrease in seizure frequency; at 1 year, 21 of 31 studied individuals had a >50% seizure decrease. Side effects were mild and transient. Quality of life scores improved significantly with time.
Volume
54
Issue
5
First Page
1179
Last Page
1182
ISSN
0028-3878
Published In/Presented At
Sirven, J. I., Sperling, M., Naritoku, D., Schachter, S., Labar, D., Holmes, M., Wilensky, A., Cibula, J., Labiner, D. M., Bergen, D., Ristanovic, R., Harvey, J., Dasheiff, R., Morris, G. L., O'Donovan, C. A., Ojemann, L., Scales, D., Nadkarni, M., Richards, B., & Sanchez, J. D. (2000). Vagus nerve stimulation therapy for epilepsy in older adults. Neurology, 54(5), 1179–1182. https://doi.org/10.1212/wnl.54.5.1179
Disciplines
Medicine and Health Sciences
PubMedID
10720294
Department(s)
Department of Medicine
Document Type
Article